Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from EHRA and ESC WG on Cardiovascular Pharmacology endorsed by HRS, APHRS, and ISCP-Authors' reply

Affiliations

Comment

G-A Dan et al. Europace. 2018.

. 2018 Nov 1;20(11):1873-1874.

doi: 10.1093/europace/euy217.

¹ Department of Cardiology, University of Medicine 'Carol Davila', University Hospital Colentina, Sos. Kiseleff 22, app.5, Bucharest, Romania.

No abstract available

Comment on

Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP).
Dan GA, Martinez-Rubio A, Agewall S, Boriani G, Borggrefe M, Gaita F, van Gelder I, Gorenek B, Kaski JC, Kjeldsen K, Lip GYH, Merkely B, Okumura K, Piccini JP, Potpara T, Poulsen BK, Saba M, Savelieva I, Tamargo JL, Wolpert C; ESC Scientific Document Group. Dan GA, et al. Europace. 2018 May 1;20(5):731-732an. doi: 10.1093/europace/eux373. Europace. 2018. PMID: 29438514 No abstract available.
Comment on 'Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from EHRA'.
Milicevic G. Milicevic G. Europace. 2018 Nov 1;20(11):1873. doi: 10.1093/europace/euy193. Europace. 2018. PMID: 30312398 No abstract available.